果凍市場：按治療方法、疾病和地區分類

Biosurgery Market, By Treatment Type, By Disease Type, By Geography

出版日期: 2026年05月12日 | 出版商:

Coherent Market Insights | 英文 158 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，果凍市場規模將達到 191.158 億美元，到 2033 年將達到 298.994 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 6.6%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	191.158億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.60%	2033年市場規模預測：	298.994億美元

果凍是一種很有前景的局部治療方法輔助手段，尤其適用於清創術。果凍利用天然、合成或半合成材料來封閉手術切口和傷口。果凍產品通常由天然、合成或半合成材料組成，有助於封閉手術切口並促進組織修復。

市場動態

心血管疾病的日益流行、老年人口的成長、先進外科器械和設備的廣泛應用、研發的增加、健康意識的提高以及醫療保健基礎設施的發展，預計這些因素將推動全球果凍市場在預測期內的成長。

例如，根據英國心臟基金會發布的《英國概況介紹（2022年8月）》，截至2021年，英國有超過760萬人患有某種形式的心臟或循環系統疾病。此外，2020年1月，Terumo Corporation在歐洲、中東和非洲市場推出了一種名為「AQUABRID」的外科密封劑。 AQUABRID是一種專為主動脈手術開發的新型外科密封劑。即使在心血管手術過程中血液凝固受到抑制的情況下，它也能安全有效地止血。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據公司亮點、產品系列、主要特點、財務表現和策略等參數，創建了全球果凍市場主要公司的概況。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球果凍市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過各種用於分析全球生物外科市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太國家
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲國家
中東
海灣合作理事會國家
以色列
其他中東國家
非洲
南非
北非
中非

第7章競爭情勢

Betatech Medical
Hemostasis LLC
CryoLife Inc.
CSL Limited
Medtronic PLC
Johnson & Johnson
B.Braun Melsungen AG
Baxter International Inc.
Integra Lifesciences Holdings Corporation
Becton, Dickinson and Company（CR Bard）

第8章

調查方法
關於本公司

簡介目錄

Product Code: CMI5457

Biosurgery Market is estimated to be valued at USD 19,115.8 Mn in 2026 and is expected to reach USD 29,899.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 19,115.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.60%	2033 Value Projection:	USD 29,899.4 Mn

Biosurgery is promising adjunct to the whole spectrum of topical treatment methods, in particular for debridement. Biosurgery involves natural, synthetic, or semi-synthetic materials to seal surgical incisions and wounds. Biosurgery products typically consist of natural, synthetic, or semi-synthetic materials that help seal surgical incisions and facilitate tissue repairs.

Market Dynamics

Increase in prevalence of cardiovascular diseases, growing geriatric population, rise in adoption of advanced surgical tools and devices, increase in research & development, rising health awareness, and developing healthcare infrastructure are major factors expected to propel growth of the global biosurgery market during the forecast period.

For instance, according to the British Heart Foundation, United Kingdom Factsheet (August 2022), more than 7.6 million people are living in the United Kingdom in 2021 with some kind of heart and circulatory diseases. Moreover, in January 2020, Terumo launched its surgical sealant named AQUABRID in the EMEA market. AQUABRID is a new surgical sealant specially developed for aortic procedures. It is safe and effective in achieving hemostasis, even when blood coagulation is inhibited during cardiac surgery.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global biosurgery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Betatech Medical, Hemostasis LLC, CryoLife Inc., CSL Limited, Medtronic PLC, Johnson & Johnson, B.Braun Melsungen AG, Baxter International Inc., Integra Lifesciences Holdings Corporation, and Becton, Dickinson and Company (CR Bard), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global biosurgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosurgery market.

Market Segmentation

By Treatment Type Insights (Revenue, USD Mn, 2021 - 2033)
- Hemostatic Agents
- Bone-graft Substitutes
- Surgical Sealants and Adhesives
- Soft-tissue Attachments
- Adhesion Barriers
- Staple Line Reinforcement
By Disease Type Insights (Revenue, USD Mn, 2021 - 2033)
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Gynecological Surgery
- Other Applications
By Region Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players in the Biosurgery Market
- Betatech Medical
- Hemostasis LLC
- CryoLife Inc.
- CSL Limited
- Medtronic PLC
- Johnson & Johnson
- Braun Melsungen AG
- Baxter International Inc.
- Integra Lifesciences Holdings Corporation
- Becton, Dickinson and Company (CR Bard)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Disease Type
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- High prevalence of heart diseases and growing geriatric population
- Lack of awareness among people about biosurgery
- Increasing adoption of advanced surgical tools and devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Biosurgery Market, By Treatment Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hemostatic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Bone-graft Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Surgical Sealants and Adhesives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Soft-tissue Attachments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Adhesion Barriers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Staple Line Reinforcement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Biosurgery Market, By Disease Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Orthopedic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
General Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Neurological Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Cardiovascular Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gynecological Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Biosurgery Market, By Geography, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021-2033, (USD Mn)
South Africa
North Africa
Central Africa

7. Competitive Landscape

Betatech Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hemostasis LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CryoLife Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
B.Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Integra Lifesciences Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company (CR Bard)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views